Clinical trial
Prevention of Deep Venous Thromboembolism: Effect of Preemptive Analgesic of Femoral Nerve Block in Patients Undergoing Total Knee Arthroplasty
NCT02411097 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Deep Venous Thromboembolism: Effect of Preemptive Analgesic of Femoral Nerve Block in Patients Undergoing Total Knee Arthroplasty
- Lead sponsor
- General Hospital of Ningxia Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- October 31, 2015
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gonarthrosis